Skip to main content

Agora
Sign in

House bill · H.R. 8205 (119th Congress)

Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026

U.S. House of Representatives

Latest action Oct 14, 2026

Sponsor: Mike Quigley (U.S. Representative, IL-5, Democratic)

Follow

Following needs an Agora account. You will sign in first, then come back to this page.

From Congress.gov and official rosters. This record was last updated Sep 8, 2026. About our data

Summary

Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026 This bill reauthorizes through FY2031 and revises programs that support research and development of drugs and other therapies to address amyotrophic lateral sclerosis (also known as ALS or Lou Gehrig's disease) and other neurodegenerative diseases. The bill reauthorizes grants from the National Institutes of Health (NIH) for scientific research on investigational drugs to prevent or treat ALS for individuals not otherwise eligible for clinical trials, grants from the Food and Drug Administration (FDA) for research and development of therapies to prevent and treat ALS and other neurodegenerative diseases, and a Public-Private Partnership including the FDA and NIH that supports development and regulatory review of treatments for neurodegenerative diseases. Also, the NIH, in considering renewal of its grants, must assess available information on the safety and efficacy of the investigational drugs. It must also require grantees to promptly report serious and unexpected adverse events associated with their investigational drugs. Additionally, the FDA must publish a plan describing actions it will take over a five-year period to foster development of safe and effective drugs, and facilitate access to investigational drugs, that treat ALS and other rare neurodegenerative diseases. The FDA must also publish a report describing the actions it has taken under the plan.

Summary from the Congressional Research Service. How we handle summaries

Where it stands

Passed one of the two chambers; it still needs the other.

  1. Introduced
  2. In committee
  3. Up for a vote
  4. Passed one chamber
  5. Passed
  6. Enacted

Committee

House Committee on Energy and Commerce · U.S. House of Representatives

Your position on this bill

Choose the position closest to yours. You'll sign in or create an account to save it.

Sign in or create an account to give your position

Cosponsors

103

Cosponsors listed on Congress.gov, shown A to Z.

  • Democratic64
  • Republican39

This bill has cosponsors from more than one party.

Shown in neutral colors by design; Agora is non-partisan.

Show the full list (103 names)

Related bills

As identified by Congress.gov.

Full history

  1. Oct 14, 2026

    Message on Senate Action Sent to the House.

    Message on Senate action sent to the House.

    U.S. Senate

  2. Sep 28, 2026

    Passed a chamber

    Passed Senate without amendment by Voice Vote. (consideration: CR S5120)

    U.S. Senate

  3. Jul 23, 2026

    Sent to the executive

    Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 466.

    U.S. Senate

  4. Jul 22, 2026

    Considered as Unfinished business. (consideration: cr H5159)

    Considered as unfinished business. (consideration: CR H5159)

  5. Jul 22, 2026

    Considered as Unfinished business. (consideration: cr H5159)

    Considered as unfinished business. (consideration: CR H5159)

Show full history (34 earlier events)
  1. Jul 22, 2026

    Considered as Unfinished business. (consideration: cr H5159)

    Considered as unfinished business. (consideration: CR H5159)

  2. Jul 22, 2026

    Passed a chamber

    Motion to reconsider laid on the table Agreed to without objection.

  3. Jul 22, 2026

    Passed a chamber

    Motion to reconsider laid on the table Agreed to without objection.

  4. Jul 22, 2026

    Passed a chamber

    Motion to reconsider laid on the table Agreed to without objection.

  5. Jul 22, 2026

    Passed a chamber

    Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.

    U.S. House of Representatives

  6. Jul 20, 2026

    At the Conclusion of Debate, the Chair Put the Question on the Motion to Suspend the rules. Mr. Guthrie Objected to the Vote on the Grounds That a Quorum Was Not present. Further Proceedings on the Motion Were postponed. the Point of no Quorum Was Considered as withdrawn.

    At the conclusion of debate, the chair put the question on the motion to suspend the rules. Mr. Guthrie objected to the vote on the grounds that a quorum was not present. Further proceedings on the motion were postponed. The point of no quorum was considered as withdrawn.

  7. Jul 20, 2026

    At the Conclusion of Debate, the Chair Put the Question on the Motion to Suspend the rules. Mr. Guthrie Objected to the Vote on the Grounds That a Quorum Was Not present. Further Proceedings on the Motion Were postponed. the Point of no Quorum Was Considered as withdrawn.

    At the conclusion of debate, the chair put the question on the motion to suspend the rules. Mr. Guthrie objected to the vote on the grounds that a quorum was not present. Further proceedings on the motion were postponed. The point of no quorum was considered as withdrawn.

  8. Jul 20, 2026

    At the Conclusion of Debate, the Chair Put the Question on the Motion to Suspend the rules. Mr. Guthrie Objected to the Vote on the Grounds That a Quorum Was Not present. Further Proceedings on the Motion Were postponed. the Point of no Quorum Was Considered as withdrawn.

    At the conclusion of debate, the chair put the question on the motion to suspend the rules. Mr. Guthrie objected to the vote on the grounds that a quorum was not present. Further proceedings on the motion were postponed. The point of no quorum was considered as withdrawn.

  9. Jul 20, 2026

    Debate - the House Proceeded With Forty Minutes of Debate on H.R. 8205.

    DEBATE - The House proceeded with forty minutes of debate on H.R. 8205.

    U.S. House of Representatives

  10. Jul 9, 2026

    Placed on the Union Calendar, Calendar No. 637.

  11. Jul 9, 2026

    Placed on the Union Calendar, Calendar No. 637.

  12. Jul 9, 2026

    Placed on the Union Calendar, Calendar No. 637.

  13. Jul 9, 2026

    Reported out of committee

    Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-733.

  14. Jul 9, 2026

    Reported out of committee

    Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-733.

  15. Jul 9, 2026

    Reported out of committee

    Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-733.

  16. May 21, 2026

    Committee vote

    Committee Consideration and Mark-up Session Held

  17. May 21, 2026

    Committee vote

    Committee Consideration and Mark-up Session Held

  18. May 21, 2026

    Committee vote

    Committee Consideration and Mark-up Session Held

  19. May 21, 2026

    Reported out of committee

    Ordered to be Reported (Amended) by the Yeas and Nays: 46 - 0.

  20. May 21, 2026

    Reported out of committee

    Ordered to be Reported (Amended) by the Yeas and Nays: 46 - 0.

  21. May 21, 2026

    Introduced

    Ordered to be Reported (Amended) by the Yeas and Nays: 46 - 0.

    U.S. House

  22. May 21, 2026

    Reported out of committee

    Ordered to be Reported (Amended) by the Yeas and Nays: 46 - 0.

  23. May 13, 2026

    In committee

    Forwarded by Subcommittee to Full Committee by Voice Vote.

  24. May 13, 2026

    In committee

    Forwarded by Subcommittee to Full Committee by Voice Vote.

  25. May 13, 2026

    In committee

    Forwarded by Subcommittee to Full Committee by Voice Vote.

  26. May 13, 2026

    Committee vote

    Subcommittee Consideration and Mark-up Session Held

  27. May 13, 2026

    Committee vote

    Subcommittee Consideration and Mark-up Session Held

  28. May 13, 2026

    Committee vote

    Subcommittee Consideration and Mark-up Session Held

  29. May 7, 2026

    Introduced

    Introduced in U.S. House

    U.S. House

  30. Apr 6, 2026

    Introduced

    Introduced in House

    U.S. House of Representatives

  31. Apr 6, 2026

    Referred to committee

    Referred to the House Committee on Energy and Commerce.

    U.S. House of Representatives

  32. Apr 6, 2026

    Referred to committee

    Referred to the Subcommittee on Health.

  33. Apr 6, 2026

    Referred to committee

    Referred to the Subcommittee on Health.

  34. Apr 6, 2026

    Referred to committee

    Referred to the Subcommittee on Health.

Read the record